Quarterly Result7 Aug 2026, 11:56 am
Transgene Biotek Declares Unaudited Q1 FY27 Results
AI Summary
Transgene Biotek Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results, along with the limited review report. The company also approved the extension of its Annual General Meeting for the financial year 2025-26, pending regulatory approval. Additionally, M/s. Manisha Dubey & Associates were appointed as the Internal Auditors for the financial year 2026-27.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Standalone and consolidated results approved.
- AGM date extension approved, subject to approvals.
- New internal auditors appointed for FY27.
Price Impact
More from TRABI